Výsledky vyhľadávania - "Kidney physiopathology"

  1. 1
  2. 2

    Zdroj: J Thromb Thrombolysis
    Liu, Y, Lam, S H M, Romiti, G F, Huang, B, Chen, Y, Chao, T F, Olshansky, B, Hong, K, Huisman, M V, Lip, G Y H & GLORIA-AF Investigators 2025, 'Renal function and adverse clinical events in anticoagulated patients with atrial fibrillation: insights from the GLORIA-AF Registry Phase III', Journal of Thrombosis and Thrombolysis, vol. 58, no. 2, pp. 165-177. https://doi.org/10.1007/s11239-025-03067-5

    Popis súboru: application/pdf

  3. 3
  4. 4

    Zdroj: J Hypertens
    Shantsila, A, Lip, G Y H & Lane, D A 2024, 'Relationship between systolic blood pressure and renal function on clinical outcomes in patients with atrial fibrillation: a report from the prospective AF-GEN-UK Registry', Journal of Hypertension, vol. 42, no. 12, pp. 2148-2154. https://doi.org/10.1097/HJH.0000000000003856

    Popis súboru: application/pdf

  5. 5
  6. 6
  7. 7

    Zdroj: Illum, E, Kofod, D H, Ballegaard, E F, Nelveg-Kristensen, K E, Hornum, M, Schou, M, Torp-Pedersen, C, Gislason, G, Lassen, J F & Carlson, N 2024, ' Coronary angiography in patients with kidney dysfunction and myocardial injury : A retrospective cohort study on management of myocardial injury in hospitalized patients with kidney disease ', Cardiovascular Revascularization Medicine, vol. 63, pp. 59-65 . https://doi.org/10.1016/j.carrev.2024.01.001

    Popis súboru: application/pdf

  8. 8

    Zdroj: Clin Exp Nephrol

  9. 9
  10. 10
  11. 11

    Zdroj: Binding, C, Blanche, P, Lip, G Y H, Kamper, A-L, Lee, C J Y, Staerk, L, Gislason, G, Torp-Pedersen, C, Olesen, J B & Bonde, A N 2024, 'Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 10, no. 3, pvae016, pp. 210-218. https://doi.org/10.1093/ehjcvp/pvae016

    Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38402466

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Zdroj: N Engl J Med
    Docusalut
    Conselleria de Salut i Consum del Govern de les Illes Balears

    Popis súboru: application/pdf

  17. 17
  18. 18

    Zdroj: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)

    Predmety: Male, Time Factors, Linagliptin, Pulse Wave Analysis, Kidney, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Glucosides, Diseases of the circulatory (Cardiovascular) system, Humans, Insulin, Diabetic Nephropathies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, PWV, Research, Middle Aged, Metformin, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, GFR decline, Female, Drug Therapy, Combination, Benzhydryl Compounds/therapeutic use [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Diabetes Mellitus, Type 2/physiopathology [MeSH], Sodium-Glucose Transporter 2 [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Metformin/therapeutic use [MeSH], Kidney/physiopathology [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Clinical Relevance [MeSH], Drug Therapy, Combination [MeSH], SGLT2 inhibitors, Glomerular Filtration Rate/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Insulin [MeSH], Linagliptin/adverse effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Diabetic Nephropathies/drug therapy [MeSH], Pulse Wave Analysis [MeSH], Vascular Stiffness/drug effects [MeSH], Glomerular Filtration Rate

  19. 19

    Zdroj: Kidney & Blood Pressure Research, Pp 1-10 (2021)

  20. 20

    Zdroj: The Lancet Diabetes & Endocrinology. 9:743-754